Skip to main content
. 2018 Sep 18;4(1):148–158. doi: 10.1016/j.ekir.2018.09.005

Table 4.

C4d+ WER sample details

Patient (based on heat map cluster location, Figure 2) Biopsy type ABO status DSA status (at time of biopsy) Time from transplant to biopsy, d Transcript geometric mean AbMR transcripts Heat map group Follow-up biopsy Follow-up biopsy type Time to follow-up, d
1 P i Negative 97 22.81 Low No Rejection No AbMR FC 665
4 FC c Negative 9 23.19 Low No Rejection None N/A 0
5 FC c Negative 11 27.16 Low No Rejection No AbMR FC 112
9 FC c Negative 40 28.67 Low No Rejection AbMR FC 1792
10 FC c Negative 115 21.38 Low No Rejection None N/A 0
11 FC c Positive 12 22.97 Low No Rejection No AbMR FC 44
12 FC c Negative 362 28.64 Low No Rejection No AbMR FC 1386
14 FC i Negative 1169 34.67 Low No Rejection No AbMR FC 755
15 FC c Negative 1530 27.19 Low No Rejection None N/A 0
16 FC c Negative 59 31.63 Low No Rejection No AbMR P 1075
17 FC c Negative 179 33.43 Low No Rejection No AbMR FC 1687
18 P i Negative 1914 31.85 Low No Rejection None N/A 0
20 FC c Negative 2853 32.22 Low No Rejection None N/A 0
22 P i Negative 1827 28.30 Low No Rejection None N/A 0
23 FC c Positive 62 31.13 Low No Rejection No AbMR P 252
25 P c Positive 495 24.78 Low No Rejection None N/A 0
29 P i Negative 1201 25.13 Low No Rejection None N/A 0
31 P i Negative 260 23.82 Low No Rejection None N/A 0
33 FC c Negative 132 44.26 Low No Rejection AbMR FC 2164
35 FC c Negative 1282 32.55 Low No Rejection No AbMR FC 1083
36 P i Negative 1886 31.87 Low No Rejection None N/A 0
38 FC c Positive 41 37.88 Low No Rejection AbMR FC 170
40 FC c Negative 44 44.52 Low No Rejection No AbMR FC 1133
41 FC c Negative 48 33.80 Low No Rejection None N/A 0
43 FC c Positive 23 33.62 Low No Rejection No AbMR FC 2483
45 FC c Positive 17 29.25 Low No Rejection AbMR FC 2370
47 FC c Positive 123 31.98 Low No Rejection AbMR FC 1262
51 FC c Positive 1822 44.81 Low No Rejection None N/A 0
52 FC c Positive 16 42.89 Low No Rejection AbMR FC 28
53 FC c Positive 17 26.55 Low No Rejection None N/A 0
55 P i Negative 1897 19.84 Low No Rejection None N/A 0
57 FC c Positive 13 22.75 Low No Rejection No AbMR FC 694
58 P c Negative 1918 28.40 Low No Rejection None N/A 0
59 FC i Negative 107 26.78 Low No Rejection None N/A 0
60 FC c Positive 18 22.42 Low No Rejection No AbMR FC 1250
62 FC c Negative 7 20.09 Low No Rejection AbMR FC 1984
65 P i Negative 238 13.59 Low No Rejection AbMR P 2932
66 FC c Positive 2422 13.09 Low No Rejection None N/A 0
67 FC c Positive 14 21.01 Low No Rejection None P 0
68 FC c Negative 565 24.38 Low No Rejection No AbMR FC 1183
69 FC c Negative 660 34.42 Low No Rejection No AbMR FC 1289
70 P i Negative 92 36.03 Low No Rejection No AbMR P 301
71 P i Negative 262 47.18 Low No Rejection None N/A 0
92 FC c Positive 37 84.80 High Rejection AbMR FC 120
95 FC c Positive 348 148.11 High Rejection AbMR FC 198
106 P c Negative 1111 66.44 High Rejection AbMR FC 2234
116 FC c Negative 23 61.94 High Rejection No AbMR C 16
117 FC c Negative 40 72.78 High Rejection AbMR P 160
119 FC c Negative 37 58.63 Low Rejection AbMR P 319
120 FC c Positive 20 59.51 High Rejection AbMR FC 9
121 FC c Negative 434 56.26 Low Rejection No AbMR FC 3108
122 FC c Negative 16 74.30 High Rejection AbMR P 340
125 FC c Positive 0 25.20 Low Rejection AbMR P 206

AbMR, antibody-mediated rejection; c, compatible; C4d+ WER, C4d-positive without evidence of rejection; DSA, donor-specific antibody; FC, for cause biopsy; I, incompatible; N/A, not applicable; P, protocol biopsy.